Table 2 Main characteristics of included trials in vitro
First author (Year) | Country | Follow up | Tooth position | CPP-ACP Group | Control Group | Outcome report | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Sample size | Type of intervention | Frequency | Sample size | Type of intervention | Frequency | |||||
Zhou 2014 [15] | China | 24 h | lower incisors | 10 | GC Tooth Mousse | tid | 10 | no treatment | no treatment | surface roughness (Ra, nm) |
Memarpour 2015 [28] | Iran | 28 d | primary canine teeth | 8 | GC Tooth Mousse | bid | 8 | no treatment | no treatment | surface roughness (Ra, nm) |
Poggio 2009 [24] | Italy | 36 h | upper incisors | 10 | GC Tooth Mousse | 0, 8, 24 and 36 h | 10 | soft drink | 0, 8, 24 and 36 h | surface roughness (Rrms, nm) |
Vyavhare 2015 [29] | India | 12 d | maxillary incisor teeth | 6 | GC Tooth Mousse | qd | 6 | deionized water | qd | Vickers microhardness (HV) |
SoaReS 2017 [30] | India | 30 d | maxillary and mandibular premolars | 12 | GC Tooth Mousse Plus | bid | 12 | no treatment | no treatment | Vickers microhardness (HV) |
Rallan 2013 [31] | India | 8 h | primary maxillary anterior teeth | 10 | GC Tooth Mousse | once | 10 | no treatment | no treatment | Knoop microhardness (KHN) |
Carvalho 2014 [32] | Brazil | 7 d | third molars | 10 | MI Paste Plus | qd | 10 | no treatment | no treatment | Knoop microhardness (KHN) |
Kargul 2012 [33] | Turkey | 18 h | first and second molars | 15 | GC Tooth Mousse | qd | 15 | remineralizing solutions | qd | Vickers microhardness (HV) |
Memarpour 2015 [28] | Iran | 28 d | primary canine teeth | 10 | GC Tooth Mousse | bid | 10 | no treatment | no treatment | Vickers microhardness (HV) |
Rirattanapong 2012 [34] | Thailand | 6 h | premolars | 10 | GC Tooth Mousse | once | 10 | no treatment | no treatment | Vickers microhardness (HV) |
Carvalho 2013 [35] | Brazil | 5 d | third molars | 12 | MI Paste Plus | qd | 12 | no treatment | no treatment | Knoop microhardness (KHN) |